Citation Impact
Citing Papers
A Mutated Soluble Neuropilin-2 B Domain Antagonizes Vascular Endothelial Growth Factor Bioactivity and Inhibits Tumor Progression
2010
P-Glycoprotein and multidrug resistance-related protein expressions in relation to technetium-99m methoxyisobutylisonitrile scintimammography findings.
2001
Sustainability of ruminant agriculture in the new context: feeding strategies and features of animal adaptability into the necessary holistic approach
2010 Standout
Multidrug resistance in cancer: role of ATP–dependent transporters
2002 Standout
A pupal transcriptomic screen identifies Ral as a target of store-operated calcium entry in Drosophila neurons
2017 StandoutNobel
Basement Membranes: Cell Scaffoldings and Signaling Platforms
2010
EGFR Antagonists in Cancer Treatment
2008 Standout
Effects of MDR1 and MDR3 P-glycoproteins, MRP1, and BCRP/MXR/ABCP on the transport of 99mTc-tetrofosmin
2000
Diabetic retinopathy
2010 Standout
Molecular imaging in living subjects: seeing fundamental biological processes in a new light
2003 Standout
Gonadotropin-Releasing Hormone is Required for Enhanced Luteinizing Hormone Subunit Gene Expressionin Vivo
1988
Targeting VEGF signalling via the neuropilin co-receptor
2012
A peptide competing with VEGF165 binding on neuropilin-1 mediates targeting of a chlorin-type photosensitizer and potentiates its photodynamic activity in human endothelial cells
2006
Brown and beige fat: development, function and therapeutic potential
2013 Standout
Beyond the Genome
2001
Somatostatin receptors and disease: Role of receptor subtypes
1996
Cancer nanotechnology: The impact of passive and active targeting in the era of modern cancer biology
2013 Standout
Cytotoxic effects of kinetin riboside on mouse, human and plant tumour cells
2004
Activation of Gpr109a, Receptor for Niacin and the Commensal Metabolite Butyrate, Suppresses Colonic Inflammation and Carcinogenesis
2014 Standout
Two Common Naturally Occurring Mutations in the Human Gonadotropin-Releasing Hormone (GnRH) Receptor Have Differential Effects on Gonadotropin Gene Expression and on GnRH-Mediated Signal Transduction
2003
Bioinorganic aspects of angiogenesis
2010
Retinopathy of prematurity
2013 Standout
Angiotensin II activates extracellular signal regulated kinases via protein kinase C and epidermal growth factor receptor in breast cancer cells
2003
The GPR54 Gene as a Regulator of Puberty
2003 Standout
Oxytocin inhibits the proliferation of MDA-MB231 human breast-cancer cellsvia cyclic adenosine monophosphate and protein kinase A
1997
Phyto-oestrogens and Western Diseases
1997 Standout
Expression of mediated P-glycoprotein multidrug resistance related to Tc-99m MIBI scintimammography results
2000
Sex steroid binding protein exerts a negative control on estradiol action in MCF-7 cells (human breast cancer) through cyclic adenosine 3',5'-monophosphate and protein kinase A.
1996
Multifunctional Peptide-Conjugated Hybrid Silica Nanoparticles for Photodynamic Therapy and MRI
2012
Controlled drug delivery vehicles for cancer treatment and their performance
2018 Standout
Targeting tumors with peptides from natural sources
2008
Diabetic Retinopathy
2012 Standout
Natural products to drugs: natural product-derived compounds in clinical trials
2008 Standout
HTLV-1 bZIP Factor Induces T-Cell Lymphoma and Systemic Inflammation In Vivo
2011 StandoutNobel
Vascular endothelial growth factor in eye disease
2008 Standout
Design and fabrication of magnetic nanoparticles for targeted drug delivery and imaging
2009 Standout
Remodelling the extracellular matrix in development and disease
2014 Standout
Multi-targeted therapy of cancer by genistein
2008 Standout
Erythropoietin as a Retinal Angiogenic Factor in Proliferative Diabetic Retinopathy
2005
Receptor‐Mediated Interactions between Colloidal Gold Nanoparticles and Human Umbilical Vein Endothelial Cells
2010
Molecular Biology of the Pituitary Gonadotropins
1990
Cell-penetrating and cell-targeting peptides in drug delivery
2008
Exploring the cellular accumulation of metal complexes
2009
Angiotensin inhibition enhances drug delivery and potentiates chemotherapy by decompressing tumour blood vessels
2013 StandoutNobel
VEGF-targeted therapy: mechanisms of anti-tumour activity
2008 Standout
Copper bis(diphosphine) complexes: radiopharmaceuticals for the detection of multi-drug resistance in tumours by PET
2000
Histone deacetylase inhibitors in clinical development
2004
Histone deacetylase inhibitors and the promise of epigenetic (and more) treatments for cancer
2006 Standout
DNA Topoisomerases and Their Poisoning by Anticancer and Antibacterial Drugs
2010 Standout
Gold Nanoparticles for Biology and Medicine
2010 Standout
Ipriflavone inhibits osteolytic bone metastasis of human breast cancer cells in a nude mouse model
2002
Targeting endothelial and tumor cells with semaphorins
2007
The status of platinum anticancer drugs in the clinic and in clinical trials
2010 Standout
Neuropilin structure governs VEGF and semaphorin binding and regulates angiogenesis
2008
Development of a chemiluminescent screening assay for detection of vascular endothelial growth factor receptor 1 ligands
2007
Tumor Angiogenesis
2008 Standout
Receptor-targeted nanocarriers for therapeutic delivery to cancer
2010
Molecular imaging of gene expression and protein function in vivo with PET and SPECT
2002
Tumor-infiltrating regulatory T cells as targets of cancer immunotherapy
2023 StandoutNobel
Butyrate affects differentiation, maturation and function of human monocyte-derived dendritic cells and macrophages
2002
Angiopoietin-like 4 is a potent angiogenic factor and a novel therapeutic target for patients with proliferative diabetic retinopathy
2015 StandoutNobel
Pathophysiology of the Neuroregulation of Growth Hormone Secretion in Experimental Animals and the Human*
1998 Standout
Tumour stem cells and drug resistance
2005 Standout
Coordinating Radiometals of Copper, Gallium, Indium, Yttrium, and Zirconium for PET and SPECT Imaging of Disease
2010 Standout
Digoxin inhibits retinal ischemia‐induced HIF‐1α expression and ocular neovascularization
2010 StandoutNobel
Importance of dosage standardization for interpreting transcriptomal signature profiles: Evidence from studies of xenoestrogens
2006
Molecular pharmacology of somatostatin receptor subtypes
1997
The emergence of cold-induced brown adipocytes in mouse white fat depots is determined predominantly by white to brown adipocyte transdifferentiation
2010
DNA Topoisomerase I Inhibitors: Chemistry, Biology, and Interfacial Inhibition
2009 Standout
Calcineurin Mediates the Gonadotropin-Releasing Hormone Effect on Expression of Both Subunits of the Follicle-Stimulating Hormone through Distinct Mechanisms
2011
Neuroendocrine Physiology of the Normal Male Gonadal Axis
1993
Nonviral Vectors for Gene Delivery
2008 Standout
Estrogen Receptor Null Mice: What Have We Learned and Where Will They Lead Us?
1999 Standout
Homocamptothecins: Synthesis and Antitumor Activity of Novel E-Ring-Modified Camptothecin Analogues
1998
The Chemical Composition and Biological Properties of Coconut (Cocos nucifera L.) Water
2009 Standout
Nanoparticles in Photodynamic Therapy
2015 Standout
The development of anticancer ruthenium(ii ) complexes: from single molecule compounds to nanomaterials
2017 Standout
Aryl−Aryl Bond Formation by Transition-Metal-Catalyzed Direct Arylation
2007 Standout
In silico analysis enabling informed design for genome editing in medicinal cannabis; gene families and variant characterisation
2019 Standout
Molecular imaging and gene therapy.
2001
Combination therapy in combating cancer
2017 Standout
Adverse Health Consequences of Performance-Enhancing Drugs: An Endocrine Society Scientific Statement
2013 Standout
Hormones and Endocrine-Disrupting Chemicals: Low-Dose Effects and Nonmonotonic Dose Responses
2012 Standout
Prolactin: Structure, Function, and Regulation of Secretion
2000 Standout
Carbon Nanomaterials for Biological Imaging and Nanomedicinal Therapy
2015 Standout
Lipophilic Peptides for Gene Delivery
2008
Activatable Photosensitizers for Imaging and Therapy
2010 Standout
Regulation of gonadotropin, thyrotropin subunit, and prolactin messenger ribonucleic acid expression by pulsatile or continuous protein kinase-C stimulation.
1995
Nutrition and fertility in ruminant livestock
2005
Modulation of the multidrug resistance P-glycoprotein: detection with technetium-99m-sestamibi in vivo.
1997
The Oxytocin Receptor System: Structure, Function, and Regulation
2001 Standout
The Effect of Nanoparticle Size, Shape, and Surface Chemistry on Biological Systems
2012 Standout
A7RC peptide modified paclitaxel liposomes dually target breast cancer
2015
Cellular uptake of nanoparticles: journey inside the cell
2017 Standout
Phase I and Pharmacokinetic Study of the Novel MDR1 and MRP1 Inhibitor Biricodar Administered Alone and in Combination With Doxorubicin
2001
HTLV-1 uses HSPG and neuropilin-1 for entry by molecular mimicry of VEGF165
2009
Works of Anna Starzec being referenced
Effect of gonadectomy on pituitary levels of mRNA encoding gonadotropin subunits and secretion of luteinizing hormone
1984
Involvement of glutathione in loss of technetium-99m-MIBI accumulation related to membrane MDR protein expression in tumor cells.
1998
β‐Adrenoceptor subtype expression and function in rat white adipocytes
1997
Lipopeptide-based liposomes for DNA delivery into cells expressing neuropilin-1
2006
Distinct heparin binding sites on VEGF165 and its receptors revealed by their interaction with a non sulfated glycoaminoglycan (NaPaC)
2008
The effect of dietary protein restriction on the secretion of LH and FSH in pre-pubertal female lambs
2003
Structure–function analysis of the antiangiogenic ATWLPPR peptide inhibiting VEGF165 binding to neuropilin-1 and molecular dynamics simulations of the ATWLPPR/neuropilin-1 complex
2007
Sodium phenylacetate enhances the inhibitory effect of dextran derivative on breast cancer cell growth in vitro and in nude mice
2001
Selection of a highly tumorigenic breast cancer cell line sensitive to estradiol to evidence in vivo the tumor-inhibitory effect of butyrate derivative monobut-3
1994
Antiangiogenic and antitumor activities of peptide inhibiting the vascular endothelial growth factor binding to neuropilin-1
2006
Vascular Endothelial Growth Factor 165 (VEGF165) Activities Are Inhibited by Carboxymethyl Benzylamide Dextran That Competes for Heparin Binding to VEGF165 and VEGF165·KDR Complexes
2001
In vitro evaluation and biodistribution of a 99mTc-labeled anti-VEGF peptide targeting neuropilin-1
2004
Proliferative responses of epithelial cells to 8‐bromo‐cyclic AMP and to a phorbol ester change during breast Pathogenesis
1994
Cyclic Adenosine Monophosphate and Phorbol Ester, like Gonadotropin-Releasing Hormone, Stimulate the Biosynthesis of Luteinizing Hormone Polypeptide Chains in a Nonadditive Manner
1989
Evidence for a growth effect of epidermal growth factor on MDA-MB-231 breast cancer cells
1994
Integrative analysis of gene expression patterns predicts specific modulations of defined cell functions by estrogen and tamoxifen in MCF7 breast cancer cells
2005
Technetium-99m-sestamibi uptake by human benign and malignant breast tumor cells: correlation with mdr gene expression.
1996
Gonadotropin-Releasing Hormone Stimulates the Synthesis of the Polypeptide Chains of Luteinizing Hormone*
1986
Molecular heterogeneity of somatostatin analogue BIM-23014C receptors in human breast carcinoma cells using the chemical cross-linking assay.
1992